Market cap
$24 Mln
Revenue (TTM)
$3 Mln
P/E Ratio
--
P/B Ratio
0.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0 %
-
ROCE
-- %
-
Industry P/E
37.31
-
EV/EBITDA
14.8
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$13.3
-
Face value
--
-
Shares outstanding
11,574,362
10 Years Aggregate
CFO
$-896.75 Mln
EBITDA
$-853.70 Mln
Net Profit
$-951.33 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
TherapeuticsMD (TXMD)
| 39.9 | 10.7 | 7.5 | 105.4 | -17.3 | -44.0 | -39.2 |
|
BSE Sensex*
| -9.1 | 1.1 | 1.2 | -4.8 | 5.8 | 6.6 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
TherapeuticsMD (TXMD)
| 89.5 | -61.5 | -59.7 | -70.2 | -50.0 | -36.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
TherapeuticsMD (TXMD)
|
2.3 | 23.8 | 3.3 | -0.2 | -171.9 | -0.8 | -- | 0.9 |
| 18.0 | 6,238.0 | 3,117.6 | 157.4 | 14.7 | -- | 37.3 | 188.9 | |
| 207.2 | 10,883.2 | 776.6 | -191.6 | -17.6 | -223.4 | -- | 130.9 | |
| 79.4 | 15,932.7 | 691.8 | -696.2 | -89.1 | -- | -- | 123.7 | |
| 119.8 | 13,215.0 | 830.8 | 54.9 | 3.2 | 8.1 | 271.7 | 18.7 | |
| 12.2 | 10,087.6 | 332,834.2 | 33,166.6 | 11.1 | 8.9 | 28.8 | 2.5 | |
| 25.1 | 11,971.8 | 5,020.0 | -199.0 | 1.6 | -3 | -- | 1.8 | |
| 287.9 | 5,707.4 | 290.5 | 197.2 | 82.5 | 19.9 | 29.6 | 5.9 | |
| 71.4 | 6,142.1 | 450.9 | 138.6 | 39.1 | 115.6 | 49 | 31.5 | |
| 150.1 | 9,129.6 | 431.8 | -136.7 | -30.8 | -30.3 | -- | 20.5 |
Shareholding Pattern
View DetailsAbout TherapeuticsMD (TXMD)
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to... menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida. Read more
-
Executive Chairman
Governor Thomas G. Thompson
-
Executive Chairman
Governor Thomas G. Thompson
-
Headquarters
Boca Raton, FL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for TherapeuticsMD (TXMD)
What is the current share price of TherapeuticsMD Inc (TXMD) Today?
The share price of TherapeuticsMD Inc (TXMD) is $2.28 (NASDAQ) as of 26-Aug-2026 16:00 EDT. TherapeuticsMD Inc (TXMD) has given a return of -17.29% in the last 3 years.
What is the current PB & PE ratio of TherapeuticsMD Inc (TXMD)?
Since, TTM earnings of TherapeuticsMD Inc (TXMD) is negative, P/E ratio is not available.
The P/B ratio of TherapeuticsMD Inc (TXMD) is 0.87 times as on 21-Aug-2026, a 89 discount to its peers’ median range of 7.75 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-33.14 |
0.70 |
2024 |
-4.55 |
0.36 |
2023 |
-2.52 |
0.89 |
2022 |
0.85 |
2.70 |
2021 |
-0.02 |
-0.03 |
What is the 52 Week High and Low of TherapeuticsMD Inc (TXMD)?
The 52-week high and low of TherapeuticsMD Inc (TXMD) are Rs 2.94 and Rs 0.99 as of 27-Aug-2026.
What is the market cap of TherapeuticsMD Inc (TXMD)?
TherapeuticsMD Inc (TXMD) has a market capitalisation of $ 24 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in TherapeuticsMD Inc (TXMD)?
Before investing in TherapeuticsMD Inc (TXMD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.